MEDEZE logo

Medeze Group Public Company Limited Stock Price

SET:MEDEZE Community·฿6.6b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 6 Fair Values set on narratives written by author

MEDEZE Share Price Performance

฿6.20
-0.70 (-10.14%)
฿6.20
-0.70 (-10.14%)
Price ฿6.20

MEDEZE Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet with high growth potential.

2 Risks
2 Rewards

Medeze Group Public Company Limited Key Details

฿776.4m

Revenue

฿196.3m

Cost of Revenue

฿580.1m

Gross Profit

฿383.7m

Other Expenses

฿196.4m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
0.18
74.71%
25.29%
0%
View Full Analysis

About MEDEZE

Founded
2010
Employees
n/a
CEO
Veerapol Khemarangsan
WebsiteView website
www.medezegroup.com

Medeze Group Public Company Limited engages in collection and storage of stem cells for use in medication in Thailand, Vietnam, Cambodia, Philippines, and internationally. The company operates through four segments: Stem Cells; Natural Killer Cells; Others; and Sales of Products. It also provides sorting, cultivation, and development of stem cells; testing services to test the performance and count the number of natural killer cells. In addition, the company is involved in research, develops, and collects data on all types of human cellular activities and medical laboratory tests. Further, the company sells dietary supplements, cosmetics, and dermo cosmetics. Medeze Group Public Company Limited was founded in 2010 and is based in Nakhon Pathom, Thailand.

Recent MEDEZE News & Updates

Recent updates

No updates